These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38279527)

  • 1. Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
    Kriemler L; Rudin S; Gawinecka J; Gross F; Arnold M; Schweizer J; Westphal L; Inauen C; Pokorny T; Dittrich T; Toebak A; Arnold M; Christ-Crain M; von Eckardstein A; Rentsch K; Katan M; De Marchis GM
    Eur Stroke J; 2024 Jun; 9(2):494-500. PubMed ID: 38279527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness.
    Qu G; Zhang Z; Zhu H
    Lipids Health Dis; 2021 Jul; 20(1):80. PubMed ID: 34325713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.
    Doi T; Langsted A; Nordestgaard BG
    Atherosclerosis; 2024 Jun; 393():117556. PubMed ID: 38678642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.
    Johannesen CDL; Langsted A; Nordestgaard BG; Mortensen MB
    J Am Coll Cardiol; 2024 Jun; 83(23):2262-2273. PubMed ID: 38839200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
    Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
    Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.
    Wilkins JT; Li RC; Sniderman A; Chan C; Lloyd-Jones DM
    J Am Coll Cardiol; 2016 Jan; 67(2):193-201. PubMed ID: 26791067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
    JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
    Ballantyne CM; Raichlen JS; Cain VA
    J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Density Lipoprotein Cholesterol and Risk of Recurrent Vascular Events in Chinese Patients With Ischemic Stroke With and Without Significant Atherosclerosis.
    Lau KK; Chua BJ; Ng A; Leung IY; Wong YK; Chan AH; Chiu YK; Chu AX; Leung WCY; Tsang AC; Teo KC; Mak HK
    J Am Heart Assoc; 2021 Aug; 10(16):e021855. PubMed ID: 34369170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential association between apolipoprotein B and LDL cholesterol and cerebral atherosclerosis according to pre-stroke statin use.
    Baik M; Nam HS; Heo JH; Lee HS; Kim YD
    Atherosclerosis; 2023 Apr; 371():14-20. PubMed ID: 36966561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk.
    Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG
    Ann Neurol; 2022 Sep; 92(3):379-389. PubMed ID: 35635038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making.
    Cole J; Otvos JD; Remaley AT
    Clin Chem; 2023 Jan; 69(1):41-47. PubMed ID: 36366949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.
    Steffen BT; Guan W; Remaley AT; Stein JH; Tattersall MC; Kaufman J; Tsai MY
    J Clin Lipidol; 2017; 11(5):1181-1191.e1. PubMed ID: 28826575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study.
    Yao T; Lu W; Ke J; Zhang H; Zhao X; Song B; Liu T; Ke Q; Liu C
    Front Endocrinol (Lausanne); 2022; 13():865863. PubMed ID: 35573992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels.
    Sayed A; Peterson ED; Virani SS; Sniderman AD; Navar AM
    JAMA Cardiol; 2024 Aug; 9(8):741-747. PubMed ID: 38865115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.